Omada Health, Inc.
NMS: OMDALive Quote
📈 ZcoreAI Score
Our AI model analyzes Omada Health, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get OMDA Z-Score →About Omada Health, Inc.
Healthcare
Health Information Services
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.
📊 Fundamental Analysis
Omada Health, Inc. demonstrates a profit margin of -4.9%, which is below the sector average, suggesting competitive pressure.
The company recently reported 58.1% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is -8.7%, which indicates that capital utilization is currently under pressure.
At a current price of $11.41, OMDA currently trades near the bottom of its 52-week range (6%), indicating potential value or weakness (Range: $10.28 - $28.40).
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
Key Financials
Market Cap
$672.34M
Trailing P/E
--
Forward P/E
31.82
Beta (5Y)
--
52W High
$28.40
52W Low
$10.28
Avg Volume
1.37M
Day High
Day Low